FDA assigns GDUFA goal date of April 29, 2024 Milestone builds upon PharmaTher’s commitment toward unlocking the potential of ketamine for unmet medical.
TORONTO, Sept. 06, 2023 PharmaTher Holdings Ltd. , a commercial-focused specialty pharmaceutical company, is pleased to announce it has submitted a priority original Abbreviated New Drug.
Data Bridge Market research has recently released expansive research titled Global Psychedelic Drugs Market guarantees you will remain better informed than your competition. This study provides the broader perspective of the market place with its comprehensive market insights and analysis which eases surviving and s.
PharmaTher Holdings Ltd. (OTC:PHRRF – Get Free Report)’s stock price traded down 9.4% during trading on Monday . The company traded as low as $0.12 and last traded at $0.13. 523,489 shares traded hands during mid-day trading, an increase of 205% from the average session volume of 171,875 shares. The stock had previously closed at […]
PharmaDrug Inc : PharmaDrug Announces Strategic Investment in Sairiyo Therapeutics Inc finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.